title: Safe use of oral isotretinoin after pseudo-tumor cerebri due to minocycline.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Bettoli
authors.forename: Alessandro
authors.initials: A
authors.lastname: Borghi
authors.forename: Lucia
authors.initials: L
authors.lastname: Mantovani
authors.forename: Rita
authors.initials: R
authors.lastname: Scorrano
authors.forename: Sara
authors.initials: S
authors.lastname: Minghetti
authors.forename: Giulia
authors.initials: G
authors.lastname: Toni
authors.forename: Oriele
authors.initials: O
authors.lastname: Sarno
authors.forename: Stefania
authors.initials: S
authors.lastname: Zauli
authors.forename: Annarosa
authors.initials: A
authors.lastname: Virgili
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy; D000284:Administration, Oral; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000008:administration & dosage / Q000627:therapeutic use*; D008911:Minocycline / Q000009:adverse effects*; D011559:Pseudotumor Cerebri / Q000139:chemically induced*
chemical_list: D000900:Anti-Bacterial Agents; D015474:Isotretinoin; D008911:Minocycline